Short-term outcomes among patients with subclinical hypothyroidism undergoing primary percutaneous coronary intervention
Ghana Medical Journal · 2023
DOI: 10.4314/gmj.v57i1.6 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Ghana Medical Journal, 2023. Verfasst von Abdulameer J Al-Gburi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, al-Mustansiriyah University, Baghdad, Iraq. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Hypothyroidism, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
This study aimed to examine possible associations between previously undiagnosed subclinical hypothyroidism and short-term outcomes and mortality in a sample of Iraqi patients undergoing primary percutaneous coro-nary intervention for ST-segment elevation myocardial infarction.
Design
This is a prospective observational cohort study.
Setting
The study was conducted in a single tertiary referral centre in Baghdad, Iraq.
Participants
Thyroid-stimulating hormone and free T4 levels were measured in 257 patients hospitalised with ST-elevation myocardial infarction who underwent primary percutaneous coronary intervention between January 2020 and March 2022.Main outcome measures: Adverse cardiovascular and renal events during hospitalisation and 30-day mortality were observed.
Results
Previously undiagnosed subclinical hypothyroidism was detected in 36/257 (14%) ST-elevation myocardial infarction patients and observed more commonly in females than males. Patients with subclinical hypothyroidism had significantly worse short-term outcomes, including higher rates of suboptimal TIMI Flow (< III) (p =0.014), left ventricular ejection fraction ≤ 40% (p=0.035), Killip class >I (p=0.042), cardiogenic shock (p =0.016), cardiac arrest in the hospital (p= 0.01), and acute kidney injury (p= 0.044). Additionally, 30-day mortality was significantly higher in patients with subclinical hypothyroidism (p= 0.029).
Conclusion
Subclinical hypothyroidism previously undiagnosed and untreated had a significant association with adverse short-term outcomes and higher short-term mortality within 30 days compared to euthyroid patients undergoing primary percutaneous coronary intervention. Routine thyroid function testing during these patients' hospitalisation may be warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, College of Medicine, al-Mustansiriyah University, Baghdad, Iraq.
- Department of Obstetrics and Gynecology, College of Medicine, al-Nahrain University, Baghdad, Iraq.
- Department of Pediatrics, College of Medicine, al-Mustansiriyah University, Baghdad, Iraq.
Zitieren
APA
Al-Gburi, A. J., Al-Obaidi, S. R., & Abdullah, W. H. (2023). Short-term outcomes among patients with subclinical hypothyroidism undergoing primary percutaneous coronary intervention. Ghana Medical Journal. https://doi.org/10.4314/gmj.v57i1.6
Vancouver
Al-Gburi AJ, Al-Obaidi SR, Abdullah WH. Short-term outcomes among patients with subclinical hypothyroidism undergoing primary percutaneous coronary intervention. Ghana Medical Journal. 2023. doi:10.4314/gmj.v57i1.6
BibTeX
@article{AlGburi2023,
author = {Al-Gburi, Abdulameer J and Al-Obaidi, Saba R and Abdullah, Wasnaa H},
title = {Short-term outcomes among patients with subclinical hypothyroidism undergoing primary percutaneous coronary intervention},
journal = {Ghana Medical Journal},
year = {2023},
doi = {10.4314/gmj.v57i1.6}
}
EUVIMED